Home › Stargardt Disease › Texas
Stargardt Disease clinical trials in Texas
10 studies for Stargardt Disease are looking for participants at sites in Texas.
Cities in Texas
Study of ALK-001 on the Progression of Stargardt Disease
- Retina Foundation of the Southwest, Dallas
- Star Retina, Fort Worth
- Medical Center Ophthalmology Associates, San Antonio
RecruitingPhase 3
Ages 8 to 45 · All sexes · Updated Sep 18, 2026 · NCT07419334A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Retina Foundation of Southwest, Dallas
RecruitingPhase 1
Ages 6 and older · All sexes · Updated Sep 16, 2026 · NCT07734064A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Retina Foundation of the Southwest, Dallas
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- Retina Consultants of Texas, Bellaire
- Retina Foundation of the Southwest, Dallas
RecruitingPhase 1/2
Ages 8 to 55 · All sexes · Updated Jul 30, 2026 · NCT07161544Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
- RayTx Clinical Site, Bellaire
RecruitingPhase 1/2
Ages 16 and older · All sexes · Updated Apr 15, 2026 · NCT07439887Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Retina Foundation of Texas, Dallas
- Retina Consultants of Texas, Houston
RecruitingObservational study
Ages 5 and older · All sexes · Updated Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Retina Foundation of the Southwest, Dallas
- Retina Consultants of Texas, Houston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Retina Foundation of the Southwest, Dallas
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Retina Foundation of the Southwest, Dallas
RecruitingPhase 1/2
Ages 12 to 65 · All sexes · Updated Apr 29, 2025 · NCT06942572A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- Retina of North Texas,, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 24, 2025 · NCT06805474From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.